Amit Etkin, Alto Neuroscience CEO
Mid-stage CNS biotech Alto Neuroscience files for NYSE listing
California biotech Alto Neuroscience has filed to go public as it runs two Phase IIb trials for its two lead major …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
